Swiss pharma CDMO, Lonza, has broken ground on a new large-scale commercial spray-drying pharmaceutical manufacturing facility in Bend, Oregon (US). The company said the move will establish the Bend site as a global hub for spray-drying, an advanced manufacturing technology that helps medicines be absorbed more effectively in the body. The facility is expected to be completed in 2029.
Lonza said the investment will establish it as the leading CDMO provider of commercial-scale spray-drying capacity in the US, offering a full range of spray-dried dispersion capacity to support customers across clinical and commercial programmes. Through its integrated end-to-end offering, the company said it will support development and manufacturing of small molecules and other modalities, including biologics and mRNA.
The new facility will be equipped with two state-of-the-art spray-drying units, allowing for future capacity expansion, along with supporting infrastructure for solvent handling and storage, energy-efficient utility and process systems, and enhanced emission-control technologies.
Mr. Wolfgang Wienand, CEO of Lonza, said the investment reflects the company’s conviction that the US will remain a leading source of pharmaceutical innovation and a key market for Lonza. “By significantly expanding our commercial-scale spray-drying capabilities, we strengthen a technology that can fundamentally improve the delivery and bioavailability of medicines,” he added.
“The growing number of complex drug molecules is increasing demand for advanced particle engineering technologies. With decades of expertise in spray-drying, our Bend team helps customers address formulation challenges and progress their programmes efficiently,” commented Mr. Christian Seufert, Head of Advanced Synthesis, Lonza.
Lonza said the Bend site has nearly 50 years of history in pharmaceutical manufacturing and scientific innovation, having contributed to the evaluation or development of more than 2,000 potential medicines using advanced particle-engineering and spray-drying technologies, and supports pharmaceutical programs from early research through commercial manufacturing.


22 September, 2026 16:28:06 IST 

















